MENU
+Compare
AXGN
Stock ticker: NASDAQ
AS OF
Aug 18, 01:24 PM (EDT)
Price
$15.40
Change
+$0.47 (+3.15%)
Capitalization
686.97M

AXGN Axogen Forecast, Technical & Fundamental Analysis

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair... Show more

AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AXGN with price predictions
Aug 15, 2025

AXGN in downward trend: price may decline as a result of having broken its higher Bollinger Band on August 13, 2025

AXGN broke above its upper Bollinger Band on August 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 36 similar instances where the stock broke above the upper band. In of the 36 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The 10-day moving average for AXGN crossed bullishly above the 50-day moving average on July 15, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXGN advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 195 cases where AXGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.120) is normal, around the industry mean (59.656). P/E Ratio (0.000) is within average values for comparable stocks, (38.600). AXGN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.709). AXGN has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (3.329) is also within normal values, averaging (77.579).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AXGN is expected to report earnings to fall 41.75% to 6 cents per share on November 11

Axogen AXGN Stock Earnings Reports
Q3'25
Est.
$0.07
Q2'25
Beat
by $0.06
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.06
The last earnings report on August 05 showed earnings per share of 11 cents, beating the estimate of 5 cents. With 165.09K shares outstanding, the current market capitalization sits at 686.97M.
A.I.Advisor
published Dividends

AXGN paid dividends on February 12, 2010

Axogen AXGN Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of February 12, 2010, and an ex-dividend date of January 27, 2010. Read more...
A.I. Advisor
published General Information

General Information

a provider of products and technologies for peripheral nerve reconstruction and regeneration

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13631 Progress Boulevard
Phone
+1 386 462-6800
Employees
428
Web
https://www.axogeninc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LEGAX77.98-0.12
-0.15%
Columbia Large Cap Growth A
FICGX13.40-0.06
-0.45%
Cantor Fitzgerald Large Cap Fcs Cl A
RYRHX54.90-0.28
-0.51%
Rydex Russell 2000 H
DSCGX29.72-0.16
-0.54%
DFA US Small Cap Growth Instl
TNVAX18.11-0.12
-0.67%
1290 GAMCO Small/Mid Cap Value A

AXGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AXGN has been loosely correlated with TCMD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AXGN jumps, then TCMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
+0.20%
TCMD - AXGN
43%
Loosely correlated
+0.24%
TMDX - AXGN
38%
Loosely correlated
-1.69%
VMD - AXGN
37%
Loosely correlated
N/A
XRAY - AXGN
36%
Loosely correlated
-0.14%
GMED - AXGN
33%
Poorly correlated
+0.92%
More

Groups containing AXGN

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXGN
1D Price
Change %
AXGN100%
+0.20%
Medical/Nursing Services
industry (226 stocks)
25%
Poorly correlated
+0.70%
Health Services
industry (440 stocks)
23%
Poorly correlated
+0.56%